We are live on
!
Find out more
TA
TLS Advisors Portfolio holdings
AUM
$34M
1-Year Est. Return
11.11%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+11.11%
3 Year Est. Return
+36.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4M
AUM Growth
-$845K
(-4.2%)
Cap. Flow
-$4.49M
Cap. Flow
% of AUM
-23.08%
Top 10 Holdings %
Top 10 Hldgs %
96.33%
Holding
21
New
–
Increased
–
Reduced
6
Closed
7
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.7
quarters
Top 20 Avg Time Held
0.9
quarters
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Silvergate Capital Corporation
SI
|
+$1.39M |
| 2 |
Tesla
TSLA
|
+$739K |
| 3 |
Meta Platforms (Facebook)
META
|
+$681K |
| 4 |
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
|
+$343K |
| 5 |
Lite Strategy Inc
LITS
|
+$264K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.09% |
| 2 | Energy | 32.89% |
| 3 | Communication Services | 13.27% |
| 4 | Miscellaneous | 1.39% |
| 5 | Consumer Discretionary | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
EQT Corp
EQT
$33B
| $4.81M | 24.75% |
150,800
| – | – |
2022 Q4
1 quarter
|
|
2
Ovid Therapeutics
OVID
$480M
| $3.52M | 18.08% |
1,380,346
-110,188
| -7% | -$261K |
2022 Q4
1 quarter
|
|
3
DELISTED
Xoma
XOMA
| $2.54M | 13.08% |
120,465
-3,559
| -3% | -$74.8K |
2022 Q4
1 quarter
|
|
|
4
Meta Platforms (Facebook)
META
$1.83T
| $2.24M | 11.54% |
10,589
-4,000
| -27% | -$681K |
2022 Q4
1 quarter
|
|
5
Range Resources
RRC
$9.56B
| $1.58M | 8.15% |
59,823
| – | – |
2022 Q4
1 quarter
|
|
6
OmniAb
OABI
$696M
| $1.31M | 6.75% |
356,592
-30,000
| -8% | -$113K |
2022 Q4
1 quarter
|
|
7
Xenon Pharmaceuticals
XENE
$3.53B
| $1.21M | 6.21% |
33,756
| – | – |
2022 Q4
1 quarter
|
|
|
BLU
8
DELISTED
BELLUS Health Inc.
BLU
| $905K | 4.65% |
125,731
| – | – |
2022 Q4
1 quarter
|
|
9
Nebius Group N.V.
NBIS
$60.1B
| $337K | 1.73% |
17,811
| – | – |
2022 Q4
1 quarter
|
|
10
iShares MSCI Singapore ETF
EWS
$1.36B
| $270K | 1.39% |
13,600
| – | – |
2022 Q4
1 quarter
|
|
11
Hovnanian Enterprises
HOV
$631M
| $263K | 1.35% |
3,872
-2,600
| -40% | -$159K |
2022 Q4
1 quarter
|
|
|
12
Lite Strategy Inc
LITS
$38.6M
| $244K | 1.25% |
53,250
-47,264
| -47% | -$264K |
2022 Q4
1 quarter
|
|
13
Regeneron Pharmaceuticals
REGN
$76.9B
| $205K | 1.05% |
250
| – | – |
2022 Q4
1 quarter
|
|
|
NIRWW
14
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
| $1K | 0.01% |
10,000
| – | – |
2022 Q4
1 quarter
|
|
15
DELISTED
Affimed
AFMD
| – | – |
-16,197
| Closed | -$201K | – |
|
16
Nkarta
NKTX
$161M
| – | – |
-26,842
| Closed | -$161K | – |
|
17
Nano Dimension
NNDM
$653M
| – | – |
-22,000
| Closed | -$51K | – |
|
|
18
Tesla
TSLA
$1.51T
| – | – |
-6,000
| Closed | -$739K | – |
|
|
APTO
19
DELISTED
Aptose Biosciences, Inc.
APTO
| – | – |
-199
| Closed | -$52K | – |
|
|
20
DELISTED
Silvergate Capital Corporation
SI
| – | – |
-79,795
| Closed | -$1.39M | – |
|
|
FSTX
21
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| – | – |
-54,298
| Closed | -$343K | – |
|
Similar funds
QC
CPCM
EGI
SL
LWM
RF
MUMSS
CGIM
TLS Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, TLS Advisors held 21 positions worth $19.4M, down 4.2% from $20.3M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
TLS Advisors withdrew a net $4.49M in Q1 2023, closing 7 positions and reducing 6 holdings. Its most notable exit was Silvergate Capital Corporation, an estimated $1.39M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 50% a quarter earlier, followed by Energy and Communication Services.
- TLS Advisors's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $681K.
- TLS Advisors fully exited Silvergate Capital Corporation in Q1 2023, selling an estimated $1.39M.
- TLS Advisors's ten largest holdings make up 96% of its $19.4M portfolio in Q1 2023.
- TLS Advisors opened 0 new positions and closed 7 in Q1 2023.
- TLS Advisors's portfolio value fell 4.2% quarter-over-quarter to $19.4M.
Based on TLS Advisors's 13F filing for Q1 2023, filed 16 Nov 2023.